New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol

INTRODUCTION: With the pressing need to develop treatments that slow or stop the progression of Alzheimer’s disease, new tools are needed to reduce clinical trial duration and validate new targets for human therapeutics. Such tools could be derived from neurophysiological measurements of disease. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanskey, Juliette Helene, Kocagoncu, Ece, Quinn, Andrew J, Cheng, Yun-Ju, Karadag, Melek, Pitt, Jemma, Lowe, Stephen, Perkinton, Michael, Raymont, Vanessa, Singh, Krish D, Woolrich, Mark, Nobre, Anna C, Henson, Richard N, Rowe, James B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756184/
https://www.ncbi.nlm.nih.gov/pubmed/36521898
http://dx.doi.org/10.1136/bmjopen-2021-055135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756184/
https://www.ncbi.nlm.nih.gov/pubmed/36521898
http://dx.doi.org/10.1136/bmjopen-2021-055135

Ejemplares similares